Company profile: Protiva Bio
1.1 - Company Overview
Company description
- Provider of nucleic acid-based pharmaceutical products targeting human diseases, including cancer, influenza, Ebola, inflammatory diseases, and chronic viral infections; includes Pro 1, a tumor cell growth inhibitor.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Protiva Bio
nPoint
HQ: United States
Website
- Description: Provider of piezo flexure stages, nanopositioning software, and electronics for research and industry sectors.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full nPoint company profile →
Avadel Pharmaceuticals
HQ: Ireland
Website
- Description: Provider of specialty pharmaceutical products developed via proprietary drug delivery technology and in-licensing/acquisitions to create safe, effective, easy-to-take formulations; offers LUMRYZ, a central nervous system depressant for treating cataplexy or excessive daytime sleepiness in adults with narcolepsy, available through a restricted program.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Avadel Pharmaceuticals company profile →
Nantero
HQ: United States
Website
- Description: Provider of carbon nanotube-based semiconductor technologies, including NRAM non-volatile random access memory delivering high speed, high density, and low power for enterprise systems, automotive, and consumer electronics, and CNT FETs offering high linearity, low noise, and high bandwidth for 5G/6G communications, high-resolution image sensors, and radars.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nantero company profile →
Quantapore
HQ: United States
Website
- Description: Provider of nanopore-based analytical platforms for single-molecule analysis in proteomics and genomics and nanopore-based nucleic acid sequencing technology to advance research, drug discovery, and diagnostics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Quantapore company profile →
Nanomi
HQ: The Netherlands
Website
- Description: Provider of microsphere and nanoparticle manufacturing and long-acting release medicine development, leveraging proprietary Microsieve technology for uniform particle size and precise extended dosing, and Monosphere technology for biodegradable monodisperse particles that encapsulate active compounds for controlled, long-term release; develops products in-house and in collaboration.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nanomi company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Protiva Bio
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Protiva Bio
2.2 - Growth funds investing in similar companies to Protiva Bio
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Protiva Bio
4.2 - Public trading comparable groups for Protiva Bio
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →